Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,487
Award facts
- Contract value 100% obligated
- $3,486.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,486.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 13, 2026. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was competitively awarded without set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle valued through December 2031 that supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. Benlysta (belimumab) is a biologic treatment for systemic lupus erythematosus and other autoimmune conditions, reflecting the company's extensive portfolio covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The parent company's large-value IDC with DLA demonstrates AmerisourceBergen's established capability to meet federal procurement requirements and efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FV7R4?
SPE2DR26FV7R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV7R4 worth?
The government has obligated $3,487 on SPE2DR26FV7R4.
Is contract SPE2DR26FV7R4 an order under another contract?
Yes. SPE2DR26FV7R4 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7R4 competed?
The extent of competition for SPE2DR26FV7R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award